GHERARDI, ERMANNO
 Distribuzione geografica
Continente #
NA - Nord America 2.769
AS - Asia 2.271
EU - Europa 1.712
SA - Sud America 273
AF - Africa 117
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.149
Nazione #
US - Stati Uniti d'America 2.724
CN - Cina 1.158
SG - Singapore 486
IE - Irlanda 372
UA - Ucraina 279
BR - Brasile 213
HK - Hong Kong 213
VN - Vietnam 201
DE - Germania 181
RU - Federazione Russa 173
FI - Finlandia 166
SE - Svezia 134
GB - Regno Unito 113
IT - Italia 113
FR - Francia 108
ZA - Sudafrica 88
IN - India 56
BD - Bangladesh 28
IQ - Iraq 23
JP - Giappone 23
AR - Argentina 22
CA - Canada 22
BE - Belgio 16
ID - Indonesia 16
MX - Messico 13
NL - Olanda 12
CO - Colombia 11
ES - Italia 11
PK - Pakistan 10
SA - Arabia Saudita 9
AT - Austria 8
TR - Turchia 8
EC - Ecuador 7
KE - Kenya 7
PL - Polonia 7
UZ - Uzbekistan 6
VE - Venezuela 6
CL - Cile 5
LT - Lituania 5
BO - Bolivia 4
ET - Etiopia 4
JO - Giordania 4
NP - Nepal 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
EG - Egitto 3
KG - Kirghizistan 3
PY - Paraguay 3
AL - Albania 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EU - Europa 2
GR - Grecia 2
KR - Corea 2
LU - Lussemburgo 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
TT - Trinidad e Tobago 2
BF - Burkina Faso 1
BH - Bahrain 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
UY - Uruguay 1
Totale 7.149
Città #
Chandler 512
Dublin 370
Jacksonville 307
Nanjing 292
Singapore 267
Ashburn 226
Hong Kong 212
San Jose 184
Beijing 162
Boardman 127
Dallas 121
Nanchang 109
Johannesburg 82
Princeton 79
Lawrence 78
Wilmington 77
Hebei 75
Ann Arbor 74
Shenyang 73
Lauterbourg 68
Changsha 66
Ho Chi Minh City 62
Los Angeles 59
Medford 52
Jiaxing 45
Buffalo 44
Hanoi 42
Moscow 42
Tianjin 41
Milan 35
Hangzhou 30
Munich 27
New York 27
Helsinki 26
São Paulo 25
Shanghai 24
Woodbridge 22
Norwalk 21
Verona 20
Orem 19
Pavia 19
Tokyo 18
Chennai 17
Brussels 16
Santa Clara 16
Da Nang 14
Frankfurt am Main 14
Haiphong 14
Rio de Janeiro 12
Seattle 12
Baghdad 11
Kunming 11
Montreal 10
Zhengzhou 10
Guangzhou 9
Phoenix 9
San Francisco 9
Amsterdam 8
Council Bluffs 8
Biên Hòa 7
Falls Church 7
Nuremberg 7
Redondo Beach 7
Warsaw 7
Atlanta 6
Brooklyn 6
Denver 6
Jinan 6
London 6
Shenzhen 6
Toronto 6
Boston 5
Brasília 5
Chicago 5
Fairfield 5
Manchester 5
Mumbai 5
Nairobi 5
Poplar 5
Pune 5
Tashkent 5
The Dalles 5
Washington 5
Addis Ababa 4
Amman 4
Auburn Hills 4
Bengaluru 4
Curitiba 4
Des Moines 4
Medellín 4
New Delhi 4
Recife 4
Riyadh 4
Stockholm 4
Taizhou 4
Vienna 4
Belo Horizonte 3
Bishkek 3
Bologna 3
Bến Tre 3
Totale 4.662
Nome #
Aromatic amino acids at the surface of InlB are essential for host cell invasion by Listeria monocytogenes. 134
Characterisation of the SF/HGF gene promoter. 132
Maturazione dell’affinità anticorpale nel sistema del 2-fenil-5-ossazolone 131
A new crystal form of the NK1 splice variant of HGF/SF demonstrates extensive hinge movement and suggests that the NK1 dimer originates by domain swapping. 128
Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. 126
Co-expression of the HGF/SF and c-met genes during early mouse embryongenesis precedes reciprocal expression in adjacent tissues during organogenesis 122
Met receptor agonist proteins 122
Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit 119
Crystal structure of the beta-chain of human hepatocyte growth factor-like/macrophage stimulating protein. 119
A G2/M cell cycle block in transformed cells by contact with normal neighbors. 119
An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. 117
A role of HGF/SF in neural induction and its expression in Hensen's node during gastrulation. 116
A novel HGF/SF receptor (MET) agonist transiently delays the disease progression in an amyotrophic lateral sclerosis mouse model by promoting neuronal survival and dampening the immune dysregulation 116
Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain 115
Structural basis of hepatocyte growth factor/scatter factor and MET signalling. 113
Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis 112
Ingegneria degli anticorpi 111
Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. 111
Affinity Maturation of Antibodies in the 2-Phenyl-5-Oxazolone System 109
Multimeric compounds of a kringle domain from the hepatocyte growth factor / scatter factor (hgf/sf) 108
Structural Basis of Affinity Maturation of Antibodies in the 2- Phenyl-5-Oxazolone System 108
A Mechanistic Basis for Converting a Growth-Factor Receptor Agonist to an Antagonist. 106
A Novel Multipurpose Monoclonal Antibody for Evaluating Human c-Met Expression in Preclinical and Clinical Settings 105
Crystal structure of an engineered YopM-InlB hybrid protein 104
Dimerization of Fab fragments enables ready screening of phage antibodies that affect hepatocyte growth factor/scatter factor activity on target cells. 102
Roles of Hepatocyte Growth Factor/Scatter Factor and the Met Receptor in the Early Development of the Metanephros. 101
Epithelial scatter factor and development of the chick embryonic axis. 101
Computer-assisted mass spectrometric analysis of naturally occurring and artificially introduced cross-links in proteins and protein complexes. 101
Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis. 100
X-ray and neutron small-angle scattering analysis of the complex formed by the Met receptor and the Listeria monocytogenes invasion protein InlB 99
Developing antagonists for the Met-HGF/SF protein-protein interaction using a fragment-based approach 99
Structural basis of affinity maturation of the TEPC15/Vkappa 45.1 anti-2-phenyl-5-oxazolone antibodies. 95
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. 95
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans and improved activity in vivo. 95
The sema domain. 94
Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. 94
Inhibition of the MET Kinase Activity and Cell Growth in MET-Addicted Cancer Cells by Bi-Paratopic Linking 94
Met, metastasis, motility and more. 93
Ingegnerizzazione di mAb per scopi teraupeutici 93
Generation and characterization of novel recombinant antihERG1 scFv antibodies for cancer molecular imaging 91
Isolation of high affinity human antibodies directly from large synthetic repertoires. 88
Mutation and selection during the secondary response to 2-phenyloxazolone. 87
The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans. 86
Non-random features of the repertoire expressed by the members of one Vk gene family and V-J recombination. 84
Maturazione dell’affinità anticorpale 84
Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors. 83
Scatter factor is a fibroblast-derived modulator of epithelial cell motility. 83
Heparan sulphate-modified CD44 promotes hepatocyte grwoth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met 83
Eotaxin-1/CC chemokine ligand 11: a novel eosinophil survival factor secreted by human pulmonary artery endothelial cells 81
One man and his molecule 81
The effect of high-frequency random mutagenesis on in vitro protein evolution: a stuudy on TEM-1 beta-lactamase. 80
Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonist 79
Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. 79
HGF/SF inhibits junctional communication. 78
Original and artificial antibodies. 77
Scatter factor/hepatocyte growth factor is essential for liver development. 77
Targeting MET in cancer: rationale and progress 75
Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB 75
The structural repertoire of the human Vk domain. 74
Expression of a Cx43 deletion mutant in 3T3 A31 fibroblasts prevents PDGF-induced inhibition of cell communication and suppresses cell growth 73
Ligand-Mediated Dimerization of the Met Receptor Tyrosine Kinase by the Bacterial Invasion Protein InlB 72
Diverse and potent activities of HGF/SF in skin wound repair. 72
Structural Basis of Affinity Maturation of Antibodies in the 2-Phenyl-5-Oxazolone System 71
Protein Engineered Variants of Hepatocyte Growth Factor/Scatter Factor Promote Proliferation of Primary Human Hepatocytes and in Rodent Liver 71
Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding 69
MODIFIED HGF-1K1 POLYPEPTIDE. 69
Interactions of hepatocyte growth factor / scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. 69
Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET 68
Structural Basis of Affinity Maturation of Antibodies in the 2-Phenyl-5-Oxazolone System 68
Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis. 68
Down regulation of scatter factor in MRC 5 fibroblasts by epithelial-derived cells. A model for scatter factor modulation. 68
Insights into the structure/function of HGF/SF from studies with individual domains. 66
Michael Stoker 1918–2013 66
Glycoprotein production for structure analysis with stable, glycosylation mutant CHO cell lines established by fluorescence-activated cell sorting 61
Structural basis for agonism and antagonism of hepatocyte growth factor 61
Erratum: Targeting MET in cancer: Rationale and progress (Nature Reviews Cancer (2012) 12 (89-103)) 59
Engineering the NK1 fragment of HGF/SF as a MET receptor antagonist. 54
Engineered variants of InlB with an additional leucine-rich repeat discriminate between physiologically relevant and packing contacts in crystal structures of the InlB:MET complex 51
Hepatocyte growth factor/scatter factor (HGF/SF) accelerates angiogenesis in sponge implants in mice: Modulation by L- name and NS 398 43
Totale 7.183
Categoria #
all - tutte 26.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.390


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021166 0 0 0 0 0 0 0 0 0 75 68 23
2021/2022342 6 3 5 3 10 14 12 29 21 10 49 180
2022/20231.271 125 88 41 147 142 127 0 73 482 8 17 21
2023/2024320 38 55 18 21 43 69 9 38 2 8 10 9
2024/2025903 11 91 27 44 11 40 13 61 229 26 93 257
2025/20262.159 183 164 234 255 259 149 458 144 179 134 0 0
Totale 7.183